Institute of
Human genetics
Our aim is to provide all our patients with genetic diseases with an accurate diagnosis to enable targeted individual treatment.
We conduct research to better understand the role of our genes in the development of diseases. With this knowledge, we want to offer our patients better options for prediction, prevention and ultimately personalized treatment management.
By integrating genomic information into the healthcare of our patients, we want to understand the risks for the occurrence of diseases in order to better prevent them.
In order to integrate these approaches into the care of our patients, we use high-throughput methods to analyze not only the entire human genome, but also RNA, proteins and epigenetics. By working closely with our research laboratories at the Institute of Neurogenomics at Helmholtz Zentrum München, we often gain new insights into the diagnosis and treatment options for our patients' diseases that cannot be achieved using conventional diagnostic methods. To achieve this, we are continuously improving our diagnostic processes using the latest technologies. Our patients can benefit directly from the latest research findings.
Our interdisciplinary and international team consists of physicians, scientists, bioinformaticians and a laboratory team that is closely integrated into the processes. Synergistically with clinical care, we conduct research on the molecular and cellular basis of rare diseases and common diseases. We work closely with the Institute of Neurogenomics at the Helmholtz Zentrum München, where several of our research groups are active, to uncover the causes of diseases and develop potential therapies.
Institut für Humangenetik
Trogerstraße 32 / 3. OG
81675 München
Lob- und Beschwerdemanagement
Lob und Beschwerde richten Sie bitte an das zentrale Lob- und Beschwerdemanagement des Klinikums rechts der Isar. Gerne können Sie auch eine E-Mail schreiben an muv@mri.tum.de.